EPITOPIX

Epitopix, LLC was formed in 2002 to commercialize SRP technology, and to discover new vaccine technologies that improve animal health and human food safety. Discovery and development continues today, to bring novel vaccine products to additional markets including livestock, poultry, and companion animals. Epitopix owns intellectual property rights to all of its discoveries and has out-licensed SRP Technology development rights for human medical applications to Syntiron, LLC. In 2018, Epitopix became part of the Vaxxinova team to develop and distribute products in the United States, and in 2020 changed its name to Vaxxinova US to create a global branding strategy and unify its partnerships with its global affiliates... Vaxxinova US, originally called Epitopix, began as the laboratory service division of Willmar Poultry Company (WPC) in Willmar, Minnesota. During the 1980s, WPC began to seek innovative ways to improve the health of its turkey breeding stock. In order to combat..

Also known as: Epitopix, LLC, VAXXINOVA US

Primary location: Ne Willmar United States